Sun Pharmaceutical Industries Ltd.
-2.70 (-0.16%) Sun Pharma reports 16% rise in Q3 consolidated net profit
Date: 01-02-2026Sun Pharmaceutical Industries has reported results for third quarter ended December 31, 2025 (Q3FY26).
The company has reported 38.97% fall in its net profit at Rs 705.44 crore for the third quarter ended December 31, 2025 as compared to Rs 1,155.80 crore for the same quarter in the previous year. The total income of the company decreased by 6.11% at Rs 5,867.67 crore for Q3FY26 as compared to Rs 6,249.83 crore for the corresponding quarter previous year.
On consolidated basis, the company has reported 16.03% rise in its net profit at Rs 3,368.81 crore for the third quarter ended December 31, 2025 as compared to Rs 2,903.38 crore for the same quarter in the previous year. The total income of the company increased by 13.85% at Rs 16,099.38 crore for Q3FY26 as compared to Rs 14,141.08 crore for the corresponding quarter previous year.